CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Lung cancer is the leading cause of cancer-related death worldwide. Despite treatment advances, high rates of tumor recurrence emphasize the need for new therapeutic strategies. Tumors often acquire mechanisms to avoid detection by the immune system, allowing them to develop and meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Asa P. Y., Khavkine Binstock, Sharon S., Thu, Kelsie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649163/
https://www.ncbi.nlm.nih.gov/pubmed/37958404
http://dx.doi.org/10.3390/cancers15215229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649163/
https://www.ncbi.nlm.nih.gov/pubmed/37958404
http://dx.doi.org/10.3390/cancers15215229

Ejemplares similares